Background
This alteration in the policy of COVID-19 resulted in widespread infections throughout China. Most people only need some antiviral drugs such as lopinavir/ritonavir or Chinese herbal preparations for treatment. In this context, the lack of drug knowledge and inadequate drug availability are evident. This study aims to explore the factors influencing drug use and demand during the COVID-19 epidemic.
Methods
This study used quota sampling based on gender, age, and place of residence to perform a cross-sectional survey on a sample of 771 adults. The researchers used chi-square tests to understand differences in drug use and demand across characteristics, and binary logistic regression to analyse the influencing factors.
Results
The study revealed that 85.9% of the participants used drugs following the COVID-19 infection. Participants with college and above, (OR=2.49, 95% CI=1.27–4.88) annual personal income between 30,000 and 80,000CNY (OR=2.19, 95% CI=1.35–3.55) and over 80,000CNY (OR=1.96, 95% CI=1.05–3.66) were more knowledgeable about using drugs. Gender, (OR=0.69, 95% CI=0.50–0.95) age, (OR=2.11, 95% CI=1.15–3.88) residence, (OR=1.58, 95% CI=1.06–2.37) chronic disease conditions (OR=0.46, 95% CI=0.27–0.78) and infection symptoms (OR=0.60, 95% CI=0.38–0.93) as factors influencing the need for drug delivery services. (P<0.05).
Conclusion
Research has revealed that a significant proportion of infected people in China chose drug treatment during COVID-19. Individuals with severe symptoms use more medication and require more drug delivery and storage. Low-education and low-income populations are lacking in drug knowledge, and older adults with underlying medical conditions are more likely to need drug delivery services. Therefore, governments should prioritize vulnerable groups when formulating drug policies and target drug literacy and guidance. In addition, it is recommended that a drug distribution system be set up within the community so that those in need can have quick and easy access to drugs.